SIMONSEN MILL, INC. – Trademark Portfolio

Entity Type: 03

SIMONSEN MILL, INC. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 5 Nice Classification classes. The owner is based in QUIMBY, IA.

BOX 157

QUIMBY, IA 51049

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

SIMONSEN MILL, INC.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (2 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

31
Natural Agricultural Products (2 filings)

Raw and unprocessed agricultural, aquacultural, horticultural and forestry products

12
Vehicles (2 filings)

Vehicles; apparatus for locomotion by land, air or water

Frequently Asked Questions

How many trademarks does SIMONSEN MILL, INC. have?

SIMONSEN MILL, INC. has 5 U.S. trademarks filed with the USPTO.

What trademark classes does SIMONSEN MILL, INC. file in?

SIMONSEN MILL, INC. files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 31 (Natural Agricultural Products), Class 12 (Vehicles). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is SIMONSEN MILL, INC.'s trademark registration success rate?

SIMONSEN MILL, INC. has a 0% trademark registration rate, with 0 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.